Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buffered 2% Hypertonic Saline in Posterior Spinal Fusion
NCT06822374Phase 3Withdrawn
- Start
- Dec 2025
- Primary completion
- May 2028
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of hypertonic saline in scoliosis. Planned start Dec 2025; status: withdrawn.
02
Drugs
hypertonic saline
03
Conditions
scoliosis
Beyond the preview
Go deeper on NCT06822374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06822374.